Market Overview:
The global hypotaurine market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for healthy food and beverages, increasing awareness about the benefits of hypotaurine, and growing demand from emerging markets. However, stringent regulations governing the use of additives in food products may restrain the growth of this market during the forecast period. On the basis of type, greater than or equal to 98% segment is expected to account for a major share of the global hypotaurine market during 2018-2030. This segment is projected to grow at a CAGR of 6% overthe forecast period due its high purity and superior quality compared with other types available in the market. On th e basis o f application , h ealthy foo d an d drink segm en t i s expec ted t o ac count for th e major share o f th e globa l hy p otaurin e mark et du ri ng 2 018 -2 028 . Thi s segm en t i s projec ted t o gr ow at a CA GR o f 5 % ov erth e fo recas t per iod du es its hig h purit y an d superio r qu alit y co mp ared wi th other typ es availab le in th e mark et .
 Industry Outlook.svg)
Product Definition:
Hypotaurine is a natural amino acid which has been found to be effective in the treatment of anxiety and stress. It is also known to improve cognitive function and memory.
Greater than or equal to98%:
Hypotaurine (CAS 300-84-5) is a colorless and water-soluble organic compound. It has a strong odor similar to that of garlic or rotten eggs. It is soluble in alcohol, ether, acetone and water; however, it is insoluble in benzene and chloroform. Hypotaurine exists as two enantiomers: S-enantiomer and R-enantiomer which are both racemic mixtures.
Others:
Others is a chemical, which is produced by the fermentation of bacteria. It consists of organic compounds and inorganic compounds. The others segment includes products such as alcohols, ketones, lactams & lactates esters (amide), amides & imides (imide), glycolic acid derivatives (glycolic acid and its derivatives), formamidines, fumaric acid esters (fumaric acid and its derivative) acetic acids anhydrides.
Application Insights:
Healthy food, drink, feed and medicine were the major application segments of the global hypotaurine market. Medicine was the largest segment in 2017 owing to extensive usage as an expectorant and cough suppressant. Other applications include its use as a preservative in cosmetics and pharmaceuticals. The other applications are expected to witness growth with increasing demand for cosmetic products across various regions including Asia Pacific, North America, Latin America etc.
The healthy food application is projected to witness significant growth over the forecast period due to rising consumer awareness regarding health benefits associated with it such as antioxidant properties that help reduce aging effects on skin etc. Minotaurine has been used for centuries by different cultures around the world for their religious practices; however there is limited scientific evidence supporting its benefits over traditional medicines or herbs which may be substituted for it instead of medicinal use of hypotaurine among others such as dietary supplements & functional foods among many others (healthy food).
Regional Analysis:
Asia Pacific is expected to be the largest as well as the fastest-growing regional market over the forecast period. The growth can be attributed to increasing product demand in countries, such as China and India. In addition, rising awareness regarding health benefits of hypotaurine coupled with growing population is anticipated to drive industry expansion over the coming years.
Europe accounted for a significant share of global revenue in 2017 owing to high consumption levels of Minotaur in several European countries, including Germany and France. Moreover, presence of major manufacturers across this region will support industry expansion during the forecast period.
Growth Factors:
- Increasing demand from pharmaceutical and nutraceutical industries for the use of hypotaurine in various formulations
- Growing research and development activities for the use of hypotaurine in new drug discovery programs
- Rising awareness about the health benefits of hypotaurine among consumers
- Increasing investment by manufacturers in production capacity expansion projects
- Growing export opportunities for hypotaurine products
Scope Of The Report
Report Attributes
Report Details
Report Title
Hypotaurine (CAS 300-84-5) Market Research Report
By Type
Greater than or equal to98%, Others
By Application
Healthy Food, Drink, Feed, Medicine, Other
By Companies
Qianjiang Yongan Pharmaceutical, China Grand Pharmaceutical, Jiangyin Huachang Food Additive, Jiangsu Yuanyang Pharmaceutical, Taisho Pharmaceutical, Kasano Kosan Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Hypotaurine (CAS 300-84-5) Market Report Segments:
The global Hypotaurine (CAS 300-84-5) market is segmented on the basis of:
Types
Greater than or equal to98%, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Healthy Food, Drink, Feed, Medicine, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Qianjiang Yongan Pharmaceutical
- China Grand Pharmaceutical
- Jiangyin Huachang Food Additive
- Jiangsu Yuanyang Pharmaceutical
- Taisho Pharmaceutical
- Kasano Kosan Corporation
 Market Overview.svg)
Highlights of The Hypotaurine (CAS 300-84-5) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Greater than or equal to98%
- Others
- By Application:
- Healthy Food
- Drink
- Feed
- Medicine
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hypotaurine (CAS 300-84-5) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hypotaurine is a white crystalline powder with a bitter taste. It is used as an additive in food and beverages to improve flavor.
Some of the key players operating in the hypotaurine (cas 300-84-5) market are Qianjiang Yongan Pharmaceutical, China Grand Pharmaceutical, Jiangyin Huachang Food Additive, Jiangsu Yuanyang Pharmaceutical, Taisho Pharmaceutical, Kasano Kosan Corporation.
The hypotaurine (cas 300-84-5) market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hypotaurine (CAS 300-84-5) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hypotaurine (CAS 300-84-5) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hypotaurine (CAS 300-84-5) Market - Supply Chain
4.5. Global Hypotaurine (CAS 300-84-5) Market Forecast
4.5.1. Hypotaurine (CAS 300-84-5) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hypotaurine (CAS 300-84-5) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hypotaurine (CAS 300-84-5) Market Absolute $ Opportunity
5. Global Hypotaurine (CAS 300-84-5) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Type
5.3.1. Greater than or equal to98%
5.3.2. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hypotaurine (CAS 300-84-5) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Application
6.3.1. Healthy Food
6.3.2. Drink
6.3.3. Feed
6.3.4. Medicine
6.3.5. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hypotaurine (CAS 300-84-5) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hypotaurine (CAS 300-84-5) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hypotaurine (CAS 300-84-5) Demand Share Forecast, 2019-2026
9. North America Hypotaurine (CAS 300-84-5) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Application
9.4.1. Healthy Food
9.4.2. Drink
9.4.3. Feed
9.4.4. Medicine
9.4.5. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Type
9.7.1. Greater than or equal to98%
9.7.2. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hypotaurine (CAS 300-84-5) Demand Share Forecast, 2019-2026
10. Latin America Hypotaurine (CAS 300-84-5) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Application
10.4.1. Healthy Food
10.4.2. Drink
10.4.3. Feed
10.4.4. Medicine
10.4.5. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Type
10.7.1. Greater than or equal to98%
10.7.2. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hypotaurine (CAS 300-84-5) Demand Share Forecast, 2019-2026
11. Europe Hypotaurine (CAS 300-84-5) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Application
11.4.1. Healthy Food
11.4.2. Drink
11.4.3. Feed
11.4.4. Medicine
11.4.5. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Type
11.7.1. Greater than or equal to98%
11.7.2. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hypotaurine (CAS 300-84-5) Demand Share, 2019-2026
12. Asia Pacific Hypotaurine (CAS 300-84-5) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Application
12.4.1. Healthy Food
12.4.2. Drink
12.4.3. Feed
12.4.4. Medicine
12.4.5. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Type
12.7.1. Greater than or equal to98%
12.7.2. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hypotaurine (CAS 300-84-5) Demand Share, 2019-2026
13. Middle East & Africa Hypotaurine (CAS 300-84-5) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Application
13.4.1. Healthy Food
13.4.2. Drink
13.4.3. Feed
13.4.4. Medicine
13.4.5. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hypotaurine (CAS 300-84-5) Market Size and Volume Forecast by Type
13.7.1. Greater than or equal to98%
13.7.2. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hypotaurine (CAS 300-84-5) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hypotaurine (CAS 300-84-5) Market: Market Share Analysis
14.2. Hypotaurine (CAS 300-84-5) Distributors and Customers
14.3. Hypotaurine (CAS 300-84-5) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Qianjiang Yongan Pharmaceutical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. China Grand Pharmaceutical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Jiangyin Huachang Food Additive
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Jiangsu Yuanyang Pharmaceutical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Taisho Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Kasano Kosan Corporation
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
